Protein Design and Structure

Rossen Donev

ISBN 10: 0323992293 / ISBN 13: 9780323992299

Published by Elsevier Science and Technology, GB, 2022

About this Item

Protein Design and Structure, Volume 130 in the Advances in Protein Chemistry and Structural Biology series, highlights new advances in the field, with this new volume presenting interesting chapters. Each chapter is written by an international board of authors.

Seller Inventory # LU-9780323992299

Bibliographic Details

• Title: Protein Design and Structure
• Publisher: Elsevier Science and Technology, GB
• Publication Date: 2022
• Language: English
• ISBN 10: 0323992293
• ISBN 13: 9780323992299
• Binding: Hardback
• Condition: New
• Weight: 840 grams

About this title

Synopsis

Protein Design and Structure, Volume 130 in the Advances in Protein Chemistry and Structural Biology series, highlights new advances in the field, with this new volume presenting interesting chapters. Each chapter is written by an international board of authors.

• Provides the authority and expertise of leading contributors from an international board of authors
• Presents the latest release in the Advances in Protein Chemistry and Structural Biology series
• Includes the latest information on protein design and structure

About the Author

Rossen Donev received his PhD degree in 1999 from the Institute of Molecular Biology, Bulgarian Academy of Sciences. He did postdoctoral training at Imperial Cancer Research Fund, UK (renamed after the merger with Cancer Research Campaign to Cancer Research UK, London Research Institute) and Cardiff University. In 2007 he was awarded a New Investigator Grant Award from the Medical Research Council (UK) to establish himself as an independent Principle Investigator. In 2010 Dr. Donev was appointed Senior Lecturer at Swansea University. In 2016 Dr. Donev joined MicroPharm Ltd (UK) where currently he is Head of Research. He has published more than 60 research papers, chaired scientific meetings and given invited plenary talks. Rossen Donev has consulted on projects related to development of treatments for neurodevelopmental disorders and cancer therapies. He serves as Editor-in-Chief of the Advances in Protein Chemistry and Structural Biology and on editorial board of several other journals. His research interests include signaling pathways involved in neuropsychiatric disorders and tumor escape from the immune system, and development of therapeutic strategies for their treatment. More recently he has focused on development of immunotherapeutics for non-systemic applications.